This announcement is a separate document:
亚太药业：关于公司注射用盐酸地尔硫卓首家通过仿制药一致性评价的公告
Asia Pacific Pharmaceutical: Announcement on the company\'s first generic drug consistency evaluation for injectable diltiazem hydrochloride
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.